US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist
  • 15.730
  • +0.330+2.14%
Close May 10 16:00 ET
401.66MMarket Cap-1272P/E (TTM)

LENZ Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

LENZ Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-3.53

-611.39%
Analyst Rating

Strong Buy

May 9, 2024

LENZ Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 0.000--

LENZ Therapeutics Earnings Reports

  • LENZ Therapeutics | 10-Q: Quarterly report

    May 8 16:17

  • Graphite Bio | 10-K: Annual report

    Feb 27 15:20

  • Graphite Bio: Q3 2023 Earnings Report

    Nov 13, 2023 15:10

  • Graphite Bio | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:04

    • Read more

    Analysis

    Analyst Rating

    Updated: May 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg